IP Library Granted Patent US 7,186,557
Granted Patent B2
US 7,186,557 · App. 10/461,795 · Granted Mar 6, 2007

Methods of producing neurons

Assignee: Isolagen Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,557
App. No.
10/461,795
Granted
Mar 6, 2007
Kind
B2
Abstract

The invention provides a method of producing neurons from undifferentiated mesenchymal cells (UMC). Also featured by the invention is an isolated neuron produced by this method, compositions containing such neurons, and a method of repairing damaged or defective neural tissues using such compositions.

Claims (18)

1. A method of producing neurons, the method comprising: incubating a population of mammalian cells in a plasma clot containing about 6 mM to about 18 mM Ca2+,

wherein the mammalian cells are: (i) human or rat cells; and (ii) skin cells, fat tissue cells, or bone marrow cells, and

wherein the incubation is carried out in a culture medium comprising one or more additives selected from the group consisting of B27 supplement, epidermal growth factor, R3 long form insulin-like growth factor, basic fibroblast growth factor, and leukemia inhibitory factor, wherein during the incubation neurons appear in the plasma clot.

2. The method of claim 1 , wherein population of cells is a population of skin cells.

3. The method of claim 1 wherein the population of cells is a population of fat tissue cells.

4. The method of claim 1 , wherein the population of cells is a population of non-adherent derivative cells, the non-adherent derivative cells produced by a process comprising:

(a) culturing starting cells obtained from a tissue selected from the group consisting of skin, fat, and bone marrow; and

(b) harvesting the population of non-adherent derivative cells from said culture.

5. The method of claim 4 , the process further comprising one or more rounds of derivitization comprising repeating steps (a) and (b) utilizing the harvested population of non-adherent derivative cells from the previous round as the starting cells.

6. The method of claim 5 , wherein the one or more additional rounds of derivatization comprises from one to twenty rounds.

7. The method of claim 4 , further comprising culturing said non-adherent cells in the presence of acidic fibroblast growth factor.

8. The method of claim 1 , further comprising harvesting the population of neurons from the plasma clot.

9. The method of claim 8 , further comprising culturing the harvested population of cells in a serum-free culture medium.

10. The method of claim 8 , wherein the population of cells is obtained from an individual to whom the neurons are administered.

11. The method of claim 4 , wherein said tissue is dermal tissue.

12. The method of claim 4 , wherein said tissue is adipose tissue.

13. The method of claim 1 , wherein the population of mammalian cells is a population of human cells.

14. The method of claim 1 , wherein the population of mammalian cells is a population of rat cells.

Assignments (3)
CHANGE OF NAME Recorded Aug 5, 2011
From: ISOLAGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 026711/0564 →
CHANGE OF NAME Recorded Jul 15, 2011
From: ISOLAGEN, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 026601/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2003
From: MARKO, OLGA MS.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 014217/0266 →
Continuity (1)
Related Publication 20040253718A1 · Dec 16, 2004